BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 11752445)

  • 21. Distinct proliferative and transcriptional effects of the D-type cyclins in vivo.
    Mullany LK; White P; Hanse EA; Nelsen CJ; Goggin MM; Mullany JE; Anttila CK; Greenbaum LE; Kaestner KH; Albrecht JH
    Cell Cycle; 2008 Jul; 7(14):2215-24. PubMed ID: 18635970
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Down-regulation of p27Kip1 expression is required for development and function of T cells.
    Tsukiyama T; Ishida N; Shirane M; Minamishima YA; Hatakeyama S; Kitagawa M; Nakayama K; Nakayama K
    J Immunol; 2001 Jan; 166(1):304-12. PubMed ID: 11123306
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Akt/protein kinase B promotes survival and hormone-independent proliferation of thyroid cells in the absence of dedifferentiating and transforming effects.
    De Vita G; Berlingieri MT; Visconti R; Castellone MD; Viglietto G; Baldassarre G; Zannini M; Bellacosa A; Tsichlis PN; Fusco A; Santoro M
    Cancer Res; 2000 Jul; 60(14):3916-20. PubMed ID: 10919669
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Interleukin-7 promotes survival and cell cycle progression of T-cell acute lymphoblastic leukemia cells by down-regulating the cyclin-dependent kinase inhibitor p27(kip1).
    Barata JT; Cardoso AA; Nadler LM; Boussiotis VA
    Blood; 2001 Sep; 98(5):1524-31. PubMed ID: 11520803
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Levels and interactions of p27, cyclin D3, and CDK4 during the formation and maintenance of the corpus luteum in mice.
    Hampl A; Pacherník J; Dvorák P
    Biol Reprod; 2000 May; 62(5):1393-401. PubMed ID: 10775192
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Transforming growth factor beta(1) selectively inhibits the cyclic AMP-dependent proliferation of primary thyroid epithelial cells by preventing the association of cyclin D3-cdk4 with nuclear p27(kip1).
    Depoortere F; Pirson I; Bartek J; Dumont JE; Roger PP
    Mol Biol Cell; 2000 Mar; 11(3):1061-76. PubMed ID: 10712520
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mouse development and cell proliferation in the absence of D-cyclins.
    Kozar K; Ciemerych MA; Rebel VI; Shigematsu H; Zagozdzon A; Sicinska E; Geng Y; Yu Q; Bhattacharya S; Bronson RT; Akashi K; Sicinski P
    Cell; 2004 Aug; 118(4):477-91. PubMed ID: 15315760
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cdk4 integrates growth stimulatory and inhibitory signals during G1 phase of hematopoietic cells.
    Ando K; Griffin JD
    Oncogene; 1995 Feb; 10(4):751-5. PubMed ID: 7862452
    [TBL] [Abstract][Full Text] [Related]  

  • 29. STAT3 down-regulates the expression of cyclin D during liver development.
    Matsui T; Kinoshita T; Hirano T; Yokota T; Miyajima A
    J Biol Chem; 2002 Sep; 277(39):36167-73. PubMed ID: 12147685
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cdc2-cyclin E complexes regulate the G1/S phase transition.
    Aleem E; Kiyokawa H; Kaldis P
    Nat Cell Biol; 2005 Aug; 7(8):831-6. PubMed ID: 16007079
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Development-dependent expression of cyclin D3 in precursor T-cell lymphoblastic leukemia/lymphoma.
    Sasaki E; Yatabe Y; Hashimoto M; Yamashita Y; Hasegawa Y; Kojima H; Nagasawa T; Mori N
    Pathol Int; 2007 Feb; 57(2):53-9. PubMed ID: 17300668
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cell cycle progression of chronic lymphocytic leukemia cells is controlled by cyclin D2, cyclin D3, cyclin-dependent kinase (cdk) 4 and the cdk inhibitor p27.
    Decker T; Schneller F; Hipp S; Miething C; Jahn T; Duyster J; Peschel C
    Leukemia; 2002 Mar; 16(3):327-34. PubMed ID: 11896535
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Notch signaling mediates G1/S cell-cycle progression in T cells via cyclin D3 and its dependent kinases.
    Joshi I; Minter LM; Telfer J; Demarest RM; Capobianco AJ; Aster JC; Sicinski P; Fauq A; Golde TE; Osborne BA
    Blood; 2009 Feb; 113(8):1689-98. PubMed ID: 19001083
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Enhanced apoptosis in the thymus of transgenic mice expressing constitutively activated forms of human Rac2GTPase.
    Lorès P; Morin L; Luna R; Gacon G
    Oncogene; 1997 Jul; 15(5):601-5. PubMed ID: 9247314
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Disruption of thymocyte development and lymphomagenesis induced by SV40 T-antigen.
    Garvin AM; Abraham KM; Forbush KA; Farr AG; Davison BL; Perlmutter RM
    Int Immunol; 1990; 2(2):173-80. PubMed ID: 1965144
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cyclin D- and E-dependent kinases and the p57(KIP2) inhibitor: cooperative interactions in vivo.
    Gómez Lahoz E; Liegeois NJ; Zhang P; Engelman JA; Horner J; Silverman A; Burde R; Roussel MF; Sherr CJ; Elledge SJ; DePinho RA
    Mol Cell Biol; 1999 Jan; 19(1):353-63. PubMed ID: 9858559
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cyclic AMP-dependent phosphorylation of cyclin D3-bound CDK4 determines the passage through the cell cycle restriction point in thyroid epithelial cells.
    Paternot S; Coulonval K; Dumont JE; Roger PP
    J Biol Chem; 2003 Jul; 278(29):26533-40. PubMed ID: 12730225
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Thymus-derived leukemia-lymphoma in mice transgenic for the Tax gene of human T-lymphotropic virus type I.
    Hasegawa H; Sawa H; Lewis MJ; Orba Y; Sheehy N; Yamamoto Y; Ichinohe T; Tsunetsugu-Yokota Y; Katano H; Takahashi H; Matsuda J; Sata T; Kurata T; Nagashima K; Hall WW
    Nat Med; 2006 Apr; 12(4):466-72. PubMed ID: 16550188
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Coupling of the cell cycle and apoptotic machineries in developing T cells.
    Xue L; Sun Y; Chiang L; He B; Kang C; Nolla H; Winoto A
    J Biol Chem; 2010 Mar; 285(10):7556-65. PubMed ID: 20068041
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cell cycle basis for the onset and progression of c-Myc-induced, TGFalpha-enhanced mouse mammary gland carcinogenesis.
    Liao DJ; Natarajan G; Deming SL; Jamerson MH; Johnson M; Chepko G; Dickson RB
    Oncogene; 2000 Mar; 19(10):1307-17. PubMed ID: 10713672
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.